Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Bloodwork is repeated at intervals appropriate to your case
The approval for manufacturing and marketing the drug for both type 2 diabetes and obesity indications was granted earlier by the Drugs Controller General of India (DCGI)
Zepbounds active ingredient is Tirzepatide, which has a dual-hormone action to support your weight loss efforts
It was approved by the FDA in 2022 for adults with obesity and those who have overweight with at least one weight-related condition, like type 2 diabetes or high blood pressure
November 2024: Pulmonary aspiration during general anesthesia or deep sedation was added
US$ 29.73
US$ 29.15
US$ 23.37
US$ 20.96
